Replies to post #465673 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

I see SAVA UP significantly today

On news that the FDA has agreed/approved up to a 36 month extension of the ongoing open-label trials that are attracting 89% of the patients completing the two Phase III Simufilam trials. This essentially removes the slight risk that the trials would be halted/interrupted due the overhanging litigation SAVA is dealing with. Edit: easy come, easy go--the shorts just dumped over 500,000 shares on the market!